(Original title: Earn Crazy!) 14 times the big demon stock, a quarterly net profit to offset the past 15 years! Stock bar quarrel)
At the time of the 14 times demon stock Jiuan Medical, some shareholders "floated" after making a big profit, saying that they wanted to donate to the company, and the result was that the stock price was retracted for two consecutive days, and the average person donated 14%, more than 30,000 yuan.
At this moment, on the evening of January 19, Jiuan Medical suddenly released a "big move" and released a 2021 performance forecast: the net profit attributable to it in 2021 was 900 million yuan to 1.2 billion yuan, an increase of 271.4% to 395.19% year-on-year. The company's net profit in the first three quarters of last year was only 50 million yuan, and if you take the middle value of the forecast, it means that you earned almost 1 billion yuan in a single quarter in the fourth quarter of last year. The fund jun calculated that Jiuan Medical made much more money in the fourth quarter of last year than the sum of the past 15 years.
As soon as the performance forecast came out, the stock bar directly fried the pan, and there were thousands of comments in less than an hour. Netizens have their own opinions, bullish that the demon stock will make a comeback, 88.88 yuan is not the end, bearish think that it is "high and good", performance cash, the top is determined.
Household kits sold in the United States to make about $1 billion in a quarter
On the evening of January 19, Jiuan Medical disclosed that the 2021 performance forecast showed that the company expects to achieve a net profit attributable to 900 million yuan to 1.2 billion yuan in 2021, an increase of 271.4% - 395.19% year-on-year, and deducting non-net profit of 850 million - 1.15 billion yuan, a sharp increase of 243% - 365%.
The announcement said that the financial data related to the performance forecast had not been pre-audited by the accounting firm. I don't know if it is to confirm the authenticity or otherwise, the company specifically emphasizes that "the performance forecast has been pre-communicated with the annual audit accounting firm, and there is no disagreement between the two sides."
The reason for the sharp increase in performance, the company said that it continued to be affected by the global new crown epidemic in 2021, and the company's new coronavirus (SARS-CoV-2) antigen home self-test OTC kit products in the US market sales performance increased significantly, prompting a substantial increase in operating performance in 2021.
The company also reminds that the company's operating performance in 2021 mainly depends on the new crown test reagent, and there is major uncertainty about whether the future performance can continue to maintain rapid growth, mainly depending on the progress of the prevention and control of the new crown epidemic in the United States, the choice of new crown testing products in the United States, the market competitiveness of the company's products and channel sales capabilities, and the future development of conventional business, please pay attention to the investment risks of the majority of investors.
Fund Jun noted that last year's third quarter report showed that the net profit attributable to the mother in the first three quarters of 2021 was 50.128 million yuan, according to which the company's net profit in the fourth quarter of 2021 is expected to reach 849 million yuan - 1.149 billion yuan, taking the middle value of the forecast of about 1 billion yuan, creating a history since the company's listing.
The fund Jun pulled a look at the past data, in fact, the company's net profit in this single quarter has exceeded its net profit in the past 15 years combined several times. From 2006 to 2020, Jiuan Medical made a loss, generally earning tens of millions of net profits in the year, and 242 million yuan in 2020 is already the highest since the listing, but it is also a small witch in the face of the fourth quarter of last year.
The fierce divergence between bulls and bears shows a hidden worry!
14 times the demon stock This performance forecast announcement was issued, the stock bar directly fried pan, less than an hour of comments over a thousand.
Overall, most shareholders believe that the performance exceeded expectations, the stock price is expected to continue to suddenly, and some shareholders reminded the performance to cash in, to beware of the peak.
Many parties said that "this company is good, know how to maintain the stock price" "last year there were so many, this year's eight billion orders have not been counted, too profitable" "one person buys a hand, nine security rose to ninety-nine."
The short side said that "the stock price is speculated in advance, the performance is cashed, and the top is determined" "88.88 yuan is the highest point in the next few years, tomorrow take advantage of the rebound to come out" "The epidemic is short-term, after the epidemic, a place of chicken feathers" "The high level is good, and one does not want to run".
Looking back at the history of this big demon stock, from the lowest 5.8 yuan start on October 29 last year to the highest touch of 88.88 yuan on January 18 this year, the cumulative increase in two and a half months has exceeded 14 times. During the period, there have been three waves of pull-ups, the first wave is from November 15 to December 1 last year, the 13 days of 12 boards, the second wave is December 13 to December 30, the closing of 14 days 11 boards, the third wave is January 11 to 17 after the beginning of the year, the collection of 5 consecutive boards.
Under such a tidal wave, many shareholders have made a lot of money. On January 17, some shareholders posted after making a lot of money, bluntly saying that they want to donate to the company. In the past two days, this wish has also been realized, Jiuan Medical fell by 5% a day, and the cumulative correction was 14%, calculated by the latest shareholders of Jiuan Medical of 179,000, and the per capita "donation" was 32,600 yuan.
Judging from the Dragon and Tiger list after the fall and stop on the 18th, retail investors rushed forward bravely, and institutions, top floating funds "Fang Xinxia" and so on made a rival set.
A cautionary situation is that from the end of the third quarter to the end of the fourth quarter of last year, the number of shareholders of Jiuan Medical increased from 60,000 to 179,000, a sharp increase of almost 2 times in one quarter. Considering the rally this year, the number of shareholders is likely to continue to rise.
The high release is good, whether it is "Hu Hansan killed back again" on Thursday, or "fellow villagers don't run", we will wait and see.